Stem cell-based gene therapy

Oncologist

Volumn 2, Issue 3, 1997, Pages 196-202

  Bagnis, Claude ^a   Mannoni, Patrice ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ALKALINE PHOSPHATASE; ANTIVIRUS AGENT; BETA GLOBULIN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; GROWTH FACTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 6; LIGAND; LIPID; LIPOSOME; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; PLASMID VECTOR; PROTEINASE; RECEPTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BETA THALASSEMIA; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; ENZYME DEFICIENCY; GENE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TRANSGENE; VIRUS PARTICLE;

EID: 0030994571     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-3-196     Document Type: Review

References (19)

1. Carter RF, Abrams-Ogg AC, Dick JE et al. Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 1992;79:356-364.
2. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996;2:1329-1337.
3. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 1995;86:101-110.
4. Blaese RM, Culver KW, Miller AD et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995;270:475-480.
5. Bordignon C, Notarangelo LD, Nobili N et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 1995;270:470-475.
6. Thierry AR, Lunardi-Iskandar Y, Bryant JL et al. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci USA 1995;92:9742-9746.
7. Malik P, McQuiston SA, Yu X-J et al. Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J Virol 1997;71:1776-1783.
8. Kotin RM. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 1994;5:793-801.
9. Jolly D. Viral vector systems for gene therapy. Cancer Gen Ther 1994;1:51-64.
10. Kiem HP, Darovsky B, von Kalle C et al. Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells. Blood 1994;83:1467-1473.
11. van Beusechem VW, Kukler A, Heidt PJ et al. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci USA 1992;89:7640-7644.
12. + cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. Blood 1996;88:107-113.
13. Dunbar CE, Cottler Fox M, O'Shaughnessy JA et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995;85:3048-3057.
14. Naldini L, Blomer U, Gallay P et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-267.
15. Cosset FL, Russel SJ. Targeting retrovirus entry. Gene Ther 1996;3:946-956.
16. + cells with a human immunodeficiency virus type-1 based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 1996;70:2581-2585.
17. Harris JD, Lemoine NR. Strategies for targeted gene therapy. Trends Genet 1996;12:400-405.
18. Cosset FL, Takouchi Y, Battini JL et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995;69:7430-7436.
19. Riviere I, Brose K, Mulligan RC. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 1995;92:6733-6737.